WANBURY
|
|
BOM : 524212     NSE : WANBURY     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : NA |
Feb 08,2023 |
Price(EOD): ₹ 43.75
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 143.06 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
WANBURY | 6.2% | -1.7% | -55.3% |
SUN PHARMACEUTICAL INDUSTRIES | 0.5% | -0.1% | 12.5% |
DIVIS LABORATORIES | -14.3% | -19.1% | -36.2% |
CIPLA | 1.4% | -4.4% | 9% |
DR REDDYS LABORATORIES | 2.7% | 3.5% | 2.1% |
TORRENT PHARMACEUTICALS | 1% | -0.4% | 14.4% |
ABBOTT INDIA | 3.8% | -4.4% | 32% |
ZYDUS LIFESCIENCES | 9.6% | 7% | 17.2% |
ALKEM LABORATORIES | 3.4% | 4.1% | -12.8% |
FUNDAMENTAL ANALYSIS OF WANBURY
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF WANBURY
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
1.91
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 74.78 Cr
[Latest Qtr - Sep2022 - Consolidated Results ] -5.88
P/B Calculated based on Book Value of Rs -24.34 Cr
[Latest Year - Mar2022 - Consolidated Results ] 0.29
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 500.13 Cr
[Latest Qtr - Sep2022 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
-56% -60% 38% |
SHARE PRICE MOMENTUM OF WANBURY
WANBURY vs SENSEX
DEBT OF WANBURY
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
71.51 -1.22 -1.39 22.97 |
-2.72 -1.02 -1.14 -1.63 |
[Last Annual Data : Mar2022]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF WANBURY
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF WANBURY
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
6% 283.84% 90.47% 87.72% |
-0.11% -21.29% -34.72% -52.66% |
QtrlyTrend |
0 | |
Latest Qtr: Sep2022 | ||
Quarterly Result Analysis → |
WANBURY related INDICES
You may also like the below Video Courses
FAQ about WANBURY
Is WANBURY good for long term investment?
As on Feb 08,2023, the Fundamentals of WANBURY look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of WANBURY . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is WANBURY UnderValued or OverValued?
As on Feb 08,2023, WANBURY is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of WANBURY ?
As on Feb 08,2023, the Intrinsic Value of WANBURY is Rs. 99.98 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 99.98
Fair Value [Median EV / Sales Model] : Rs. 108.94
Fair Value [Median Price / Sales Model] : Rs. 31.73
Estimated Median Fair Value of WANBURY : Rs. 99.98
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is WANBURY trading at a Premium or Discount?
As on Feb 08,2023, WANBURY is trading at a Discount of -56% based on the estimates of Median Intrinsic Value!